158 related articles for article (PubMed ID: 29393362)
1. Tanshinone IIA inhibits gastric carcinoma AGS cells by decreasing the protein expression of VEGFR and blocking Ras/Raf/MEK/ERK pathway.
Su CC
Int J Mol Med; 2018 Apr; 41(4):2389-2396. PubMed ID: 29393362
[TBL] [Abstract][Full Text] [Related]
2. Tanshinone IIA inhibits gastric carcinoma AGS cells through increasing p-p38, p-JNK and p53 but reducing p-ERK, CDC2 and cyclin B1 expression.
Su CC
Anticancer Res; 2014 Dec; 34(12):7097-110. PubMed ID: 25503137
[TBL] [Abstract][Full Text] [Related]
3. Tanshinone IIA inhibits human gastric carcinoma AGS cell growth by decreasing BiP, TCTP, Mcl‑1 and Bcl‑xL and increasing Bax and CHOP protein expression.
Su CC
Int J Mol Med; 2014 Dec; 34(6):1661-8. PubMed ID: 25270224
[TBL] [Abstract][Full Text] [Related]
4. Tanshinone IIA decreases the protein expression of EGFR, and IGFR blocking the PI3K/Akt/mTOR pathway in gastric carcinoma AGS cells both in vitro and in vivo.
Su CC; Chiu TL
Oncol Rep; 2016 Aug; 36(2):1173-9. PubMed ID: 27277844
[TBL] [Abstract][Full Text] [Related]
5. Tanshinone IIA decreases the migratory ability of AGS cells by decreasing the protein expression of matrix metalloproteinases, nuclear factor κB-p65 and cyclooxygenase-2.
Su CC
Mol Med Rep; 2016 Feb; 13(2):1263-8. PubMed ID: 26648518
[TBL] [Abstract][Full Text] [Related]
6. Tanshinone IIA inhibits BT-20 human breast cancer cell proliferation through increasing caspase 12, GADD153 and phospho-p38 protein expression.
Yan MY; Chien SY; Kuo SJ; Chen DR; Su CC
Int J Mol Med; 2012 May; 29(5):855-63. PubMed ID: 22322382
[TBL] [Abstract][Full Text] [Related]
7. Tanshinone IIA induces autophagic cell death via activation of AMPK and ERK and inhibition of mTOR and p70 S6K in KBM-5 leukemia cells.
Yun SM; Jung JH; Jeong SJ; Sohn EJ; Kim B; Kim SH
Phytother Res; 2014 Mar; 28(3):458-64. PubMed ID: 23813779
[TBL] [Abstract][Full Text] [Related]
8. Tanshinone IIA inhibits viral oncogene expression leading to apoptosis and inhibition of cervical cancer.
Munagala R; Aqil F; Jeyabalan J; Gupta RC
Cancer Lett; 2015 Jan; 356(2 Pt B):536-46. PubMed ID: 25304375
[TBL] [Abstract][Full Text] [Related]
9. Tan IIA inhibits H1299 cell viability through the MDM4‑IAP3 signaling pathway.
Zu Y; Wang J; Ping W; Sun W
Mol Med Rep; 2018 Feb; 17(2):2384-2392. PubMed ID: 29207086
[TBL] [Abstract][Full Text] [Related]
10. Influence of Tanshinone IIA on apoptosis of human esophageal carcinoma Eca-109 cells and its molecular mechanism.
Zhang Y; Li S; He H; Han Q; Wang B; Zhu Y
Thorac Cancer; 2017 Jul; 8(4):296-303. PubMed ID: 28407361
[TBL] [Abstract][Full Text] [Related]
11. Tanshinone IIA down-regulates the protein expression of ErbB-2 and up-regulates TNF-alpha in colon cancer cells in vitro and in vivo.
Su CC; Lin YH
Int J Mol Med; 2008 Dec; 22(6):847-51. PubMed ID: 19020785
[TBL] [Abstract][Full Text] [Related]
12. Tanshinone IIA inhibits Hep-J5 cells by increasing calreticulin, caspase 12 and GADD153 protein expression.
Cheng CY; Su CC
Int J Mol Med; 2010 Sep; 26(3):379-85. PubMed ID: 20664954
[TBL] [Abstract][Full Text] [Related]
13. Tanshinone IIA inhibits human prostate cancer cells growth by induction of endoplasmic reticulum stress in vitro and in vivo.
Chiu SC; Huang SY; Chen SP; Su CC; Chiu TL; Pang CY
Prostate Cancer Prostatic Dis; 2013 Dec; 16(4):315-22. PubMed ID: 24042854
[TBL] [Abstract][Full Text] [Related]
14. Tanshinone IIA induces growth inhibition and apoptosis in gastric cancer in vitro and in vivo.
Chen J; Shi DY; Liu SL; Zhong L
Oncol Rep; 2012 Feb; 27(2):523-8. PubMed ID: 22038415
[TBL] [Abstract][Full Text] [Related]
15. Bromodomain containing protein represses the Ras/Raf/MEK/ERK pathway to attenuate human hepatoma cell proliferation during HCV infection.
Zhang Q; Wei L; Yang H; Yang W; Yang Q; Zhang Z; Wu K; Wu J
Cancer Lett; 2016 Feb; 371(1):107-16. PubMed ID: 26620707
[TBL] [Abstract][Full Text] [Related]
16. Tanshinone IIA induces apoptosis and inhibits the proliferation, migration, and invasion of the osteosarcoma MG-63 cell line in vitro.
Zhang Y; Wei RX; Zhu XB; Cai L; Jin W; Hu H
Anticancer Drugs; 2012 Feb; 23(2):212-9. PubMed ID: 22126901
[TBL] [Abstract][Full Text] [Related]
17. HOXA3 promotes tumor growth of human colon cancer through activating EGFR/Ras/Raf/MEK/ERK signaling pathway.
Zhang X; Liu G; Ding L; Jiang T; Shao S; Gao Y; Lu Y
J Cell Biochem; 2018 Mar; 119(3):2864-2874. PubMed ID: 29073728
[TBL] [Abstract][Full Text] [Related]
18. The antitumor natural product tanshinone IIA inhibits protein kinase C and acts synergistically with 17-AAG.
Lv C; Zeng HW; Wang JX; Yuan X; Zhang C; Fang T; Yang PM; Wu T; Zhou YD; Nagle DG; Zhang WD
Cell Death Dis; 2018 Feb; 9(2):165. PubMed ID: 29416003
[TBL] [Abstract][Full Text] [Related]
19. Diterpenoid Tanshinones, the extract from Danshen (Radix Salviae Miltiorrhizae) induced apoptosis in nine human cancer cell lines.
Shen L; Lou Z; Zhang G; Xu G; Zhang G
J Tradit Chin Med; 2016 Aug; 36(4):514-21. PubMed ID: 28459519
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of Tanshinone II a inhibits malignant melanoma development through blocking autophagy signal transduction in A375 cell.
Li X; Li Z; Li X; Liu B; Liu Z
BMC Cancer; 2017 May; 17(1):357. PubMed ID: 28532456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]